Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Update

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the recipient of a large decline in short interest in the month of March. As of March 13th, there was short interest totaling 3,890 shares, a decline of 46.5% from the February 26th total of 7,265 shares. Based on an average daily volume of 71,236 shares, the short-interest ratio is presently 0.1 days.

Cardio Diagnostics Stock Up 9.4%

Shares of CDIOW opened at $0.02 on Friday. Cardio Diagnostics has a 12 month low of $0.01 and a 12 month high of $0.07. The firm’s 50 day moving average is $0.02 and its 200-day moving average is $0.02.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.